Although the STS-loaded NP treatment had no effect on renal AGT and AT1R expression, there was a synergistic effect of CKD and STS-loaded NP treatment in reducing their expression (PCKD×NP = 0.003 and 0.024, respectively). This evidence concerns the gene AGT and chronic kidney disease.